General Urology

Joint White Paper on Reprocessing of Flexible Cystoscopes

SUNA and the American Urological Association (AUA) developed a Joint White Paper on Reprocessing of Flexible Cystoscopes. While office flexible cystoscopy has become a standard urology procedure, the flexible cystoscope is a complex instrument that requires reprocessing between patients. This white paper presents a brief overview of the current guidelines for reprocessing of flexible cystoscopes and highlights particular aspects of instrument reprocessing that are unique to cystoscopy. 

Updated ~ 2018

The paper was reviewed and updated in 2018. Workgroup Members included Jodi K. Maranchie, MD, FACS (Co-Chair); Paul Maroni, MD (Co-Chair); Ashely Heller, MPH, CIC; Majdee Islam, MD; Mary Louise Lee, RN; Jennifer Bertsch, Staff; and Janet Waters, MLS, BSN, RN, Medical Librarian.

Go to the White Paper

Updated ~ 2013

Originally developed in 2009, the paper was reviewed and updated to include the latest evidence-based research in 2013. Workgroup Members included J. Quentin Clemens, MD, MSCI, Chair; Howard Goldman, MD; Victor Senese, RN; and Jennifer Bertsch, Staff.

2009

Task Force Members included J. Quentin Clemens, MD, MSCI; Robert Dowling, MD; Frances Foley, MS, RN, CURN; Howard Goldman, MD; Chris Gonzalez, MD; Christopher Tessier, MD; and Mary Anne Wasner, RN, CURN.

White Paper on Catheter-Associated Urinary Tract Infections

The American Urological Association (AUA) has developed a White Paper on Catheter-Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient. A white paper workgroup organized by the Quality Improvement and Patient Safety Committee and led by Dr. Timothy Averch drafted the paper, which was approved by the AUA Board of Directors in October 2014. Diane K. Newman, DNP, FAAN, BCB-PMD, represented SUNA on the workgroup.

The workgroup noted that while health care in general has increased its focus on catheter-associated urinary tract infection (CAUTI) prevention and the inappropriate use of catheters, much of this attention does not apply to urologic patients. Therefore, the white paper delves in to this particular area and also provides pertinent definitions pertaining to CAUTIs.

Download the White Paper

 

White Paper on the Incidence, Prevention, and Treatment of Complications Related to Prostate Needle Biopsy

In response to a noted increase in the reports of sepsis and infectious complications after prostate biopsies SUNA and the American Urological Association (AUA) collaborated to draft a white paper. An emerging pattern of fluoroquinolone resistant bacteria, lack of evidence-based, standardized regimen for pre-procedural prophylaxis, and a lack of equipment reprocessing guidelines are addressed in this white paper.

Members of the workgroup included Christopher M. Gonzalez, MD, MBA; Timothy Averch, MD; Lee Ann Boyd, MSN, ARNP, CUNP; J. Quentin Clemens, MD, MSCI; Robert Dowling, MD; Howard B. Goldman, MD; Danil V. Makarov, MD, MHS; Vic Senese, RN; and Mary Anne Wasner, BSN, CURN. Among its summary statements, the workgroup noted the following:

  • The AUA Best Practice Statement on prophylaxis for prostate biopsy indicates fluoroquinolones or 1st-, 2nd-, or 3rd-generation cephalosporins are the antimicrobials of choice. Single-dose regimens appear to be as effective as those spanning 1- or 3-days.
  • Steam sterilization is the preferred method for reprocessing reusable, heat-stable medical devices, including prostate biopsy needle guides; however, high-level disinfection is an acceptable alternative.

Download the White Paper

Pages